Vuzix (VUZI) 10-Q 12 May 15 2015 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2015	12-May-15
Document Information [Line Items]
Entity Registrant Name	Vuzix Corp
Entity Central Index Key	1463972
Current Fiscal Year End Date	-19
Entity Filer Category	Smaller Reporting Company
Trading Symbol	VUZI
Entity Common Stock, Shares Outstanding		15,909,978
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Mar-15
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2015

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2015	Dec. 31, 2014
Current Assets
Cash and Cash Equivalents	$22,884,309	$84,967
Accounts Receivable	255,126	383,533
Inventories, Net (Note 3)	1,013,467	911,949
Prepaid Expenses and Other Assets	383,136	579,000
Total Current Assets	24,536,038	1,959,449
Tooling and Equipment, Net	387,263	416,965
Patents and Trademarks, Net	419,771	423,489
Software Development Costs, Net	716,126	787,738
Debt Issuance Costs, Net	101,068	112,521
Total Assets	26,160,266	3,700,162
Current Liabilities
Accounts Payable	827,988	2,183,565
Line of Credit	0	112,500
Note Payable (Note 4)	0	37,038
Current Portion of Long-Term Debt, (Note 7)	80,097	128,425
Current Portion of Capital Leases	11,629	16,882
Customer Deposits	19,057	120,550
Unearned Revenue	68,489	53,403
Accrued Expenses (Note 5)	673,737	699,067
Income and Other Taxes Payable	29,098	35,158
Total Current Liabilities	1,710,095	3,386,588
Long-Term Liabilities
Long-Term Derivative Liability (Note 6)	175,158	13,541,138
Long-Term Portion of Term Debt, net of discount (Note 7)	1,077,009	1,088,996
Long-Term Portion of Accrued Interest	103,921	81,451
Total Long-Term Liabilities	1,356,088	14,711,585
Total Liabilities	3,066,183	18,098,173
Stockholders’ Equity (Deficit)
Preferred Stock — $.001 Par Value, 5,000,000 Shares Authorized; 49,626 Shares Issued and Outstanding March 31, 2015, and 0 Shares Outstanding on December 31, 2014	50	0
Common Stock — $.001 Par Value, 100,000,000 Shares Authorized; 15,865,141 Shares Issued and Outstanding March 31, 2015 and 11,295,387 on December 31, 2014	15,865	11,296
Additional Paid-in Capital	72,330,410	29,752,083
Accumulated Deficit	-49,252,242	-44,161,390
Total Stockholders’ Equity (Deficit)	23,094,083	-14,398,011
Total Liabilities and Stockholders’ Equity (Deficit)	$26,160,266	$3,700,162

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	49,626
Preferred Stock, Shares Outstanding	49,626	0
Common Stock, Par Value	$0.00	$0.00
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares Issued	15,865,141	11,295,387
Common Stock, Shares Outstanding	15,865,141	11,295,387

CONSOLIDATED_STATEMENT_OF_CHAN

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (USD $)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Preferred Stock
Balance at Dec. 31, 2014	($14,398,011)	$11,296	$29,752,083	($44,161,390)	$0
Balance (in shares) at Dec. 31, 2014		11,295,387			0
Stock Compensation Expense	113,084		113,084
Conversion of Note Payable	337,500	150	337,350
Conversion of Note Payable (in shares)		150,000
Stock Issues for Services	235,500	40	235,460
Stock Issues for Services (in shares)		40,000
Common Stock Awards to Officers, Directors and Law Firm	1,475,000	295	1,474,705
Common Stock Awards to Officers, Directors and Law Firm (in Shares)		295,000
Warrants Issued for Services	260,373		260,373
Exercise of Warrants	1,200,751	4,084	1,196,667
Exercise of Warrants (in shares)		4,084,754
Reclass Fair Value of Warrant Derivative Liability upon Exercise	2,826,053		2,826,053
Reclass Fair Value of Warrant Derivative Liability Upon Waiver of Certain Anti-Dilutive Provisions	8,736,412		8,736,412
Reclass Fair Value of Note Derivative Liability Upon Waiver of Certain Anti-Dilutive Provisions	2,806,942		2,806,942
Proceeds from Preferred Stock Offering	24,813,000		24,812,950		50
Proceeds from Preferred Stock Offering (in Shares)					49,626
Direct costs of preferred stock Offering	-221,669		-221,669
Net Loss	-5,090,852			-5,090,852
Balance at Mar. 31, 2015	$23,094,083	$15,865	$72,330,410	($49,252,242)	$50
Balance (in shares) at Mar. 31, 2015		15,865,141			49,626

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Sales of Products	$695,574	$649,418
Sales of Engineering Services	113,581	149,000
Total Sales	809,155	798,418
Cost of Sales — Products	585,390	390,649
Cost of Sales — Engineering Services	45,432	59,600
Total Cost of Sales	630,822	450,249
Gross Profit	178,333	348,169
Operating Expenses:
Research and Development	514,707	397,422
Selling and Marketing	357,547	364,555
General and Administrative	2,934,907	479,637
Depreciation and Amortization	59,638	99,705
Total Operating Expenses	3,866,799	1,341,319
(Loss) from Operations	-3,688,466	-993,150
Other Income (Expense)
Other Taxes	-11,774	-21,442
Foreign Exchange Gain (Loss)	5,271	-3,951
Gain (Loss) on Derivative Valuation	-1,003,427	2,575,262
Amortization of Term Debt Discount	-340,960	-6,326
Interest Expense	-51,496	-38,487
Total Other Income (Expense)	-1,402,386	2,505,056
Income (Loss) Before Provision for Income Taxes	-5,090,852	1,511,906
Provision (Benefit) for Income Taxes	0	0
Net Income (Loss)	-5,090,852	1,511,906
Preferred Stock Dividends	-358,939	0
Earnings Available to Common Shareholders	($5,449,791)	$1,511,906
Earnings (Loss) per Share (Note 2)
Basic	($0.40)	$0.15
Diluted	($0.40)	$0.13
Weighted-average Shares Outstanding:
Basic	13,561,206	9,972,105
Diluted	13,561,206	11,517,104

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash Flows from Operating Activities
Net Income (Loss)	($5,090,852)	$1,511,906
Non-Cash Adjustments
Depreciation and Amortization	59,639	99,705
Amortization of Software Development Costs in cost of sales products	71,613	0
Common Stock Awards Compensation Expense	1,475,000	0
Stock-Based Option Compensation Expense	113,084	19,347
Amortization of Term Debt Discount	340,960	6,326
Amortization of Debt Issuance Costs	11,453	0
Common Stock and Warrants Issued for Services	526,916	0
(Gain) Loss on Derivative Valuation	1,003,427	-2,575,262
(Increase) Decrease in Operating Assets
Accounts Receivable	128,407	27,130
Inventories	-101,518	-82,047
Prepaid Expenses and Other Assets	164,821	136,026
Increase (Decrease) in Operating Liabilities
Accounts Payable	-1,355,578	-146,719
Accrued Expense	-25,330	-13,700
Customer Deposits	-101,493	-72,409
Unearned Revenue	15,086	0
Income and Other Taxes Payable	-6,060	10,678
Accrued Interest	22,470	5,708
Net Cash Flows Used in From Operating Activities	-2,747,955	-1,073,311
Cash Flows from Investing Activities
Purchases of Tooling and Equipment	-18,310	-57,009
Investments in Software	0	-280,585
Investments in Patents and Trademarks	-7,909	-11,305
Net Cash Used in Investing Activities	-26,219	-348,899
Cash Flows from Financing Activities
Proceeds from Exercise of Warrants	1,200,751	1,447,425
Repayment of Capital Leases	-5,253	-8,042
Repayment of Long-Term Debt and Notes Payable	-100,813	-55,501
Proceeds from Preferred Stock Offering	24,813,000	0
Issuance Costs on Preferred Stock Offering	-221,669	0
Net Change in Lines of Credit	-112,500	0
Net Cash Flows Provided by Financing Activities	25,573,516	1,383,882
Net Increase (Decrease) in Cash and Cash Equivalents	22,799,342	-38,328
Cash and Cash Equivalents — Beginning of Period	84,967	310,140
Cash and Cash Equivalents — End of Period	22,884,309	271,812
Supplemental Disclosures
Interest Paid	17,794	32,779
Common Stock and Warrants Issued for Services, Classified as Prepaid Expense	138,625	0
Conversion of Long-Term Debt	337,500	0
Reclassification of Derivative Liability to Paid-In Capital upon Waiver of Certain Anti-Dilutive Provisions of Warrants and Convertible Debt	11,543,354	0
Reclassification of Derivative Liability Upon Warrant Exercises	$2,826,053	$0

Basis_of_Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
Basis of Presentation	Note 1 — Basis of Presentation
	The accompanying unaudited Condensed Consolidated Financial Statements of Vuzix Corporation and Subsidiaries (“the Company") have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission. Accordingly, the unaudited Condensed Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The condensed consolidated balance sheet as of December 31, 2014 was derived from the audited Consolidated Financial Statements in Form 10-K.
	The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of the Company as of December 31, 2014, as reported in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission.
	The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year.

Earnings_Loss_Per_Share

Earnings (Loss) Per Share	3 Months Ended
	Mar. 31, 2015
Earnings (Loss) Per Share
Earnings (Loss) Per Share	Note 2 – Earnings (Loss) Per Share
	Basic earnings (loss) per share is computed by dividing net income or loss by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution from the assumed exercise of stock options and warrants, and the conversion of any convertible debt and convertible preferred shares. During periods of net loss, all common stock equivalents are excluded from the diluted EPS calculation because they are antidilutive. Since the Company reported a net loss for the three months ended March 31, 2015, the calculation for basic and diluted earnings per share is considered to be the same, as the impact of potential common shares is anti-dilutive. Since the Company reported net income for the three months ended March 31, 2014, a total of 1,544,999 additional shares have been included for these diluted calculations. As of March 31, 2015 and December 31, 2014, there were 7,186,350 and 7,012,767 respectively, common stock share equivalents potentially issuable under convertible debt agreements, conversion of preferred shares, options, and warrants that could potentially dilute basic earnings per share in the future.

Inventories_Net

Inventories, Net	3 Months Ended
	Mar. 31, 2015
Inventory Disclosure [Abstract]
Inventories, Net	Note 3 — Inventories, Net
	Inventories are stated at the lower of cost (determined on the first-in, first-out or specific identification method) or market and consisted of the following as at March 31, 2015 and December 31, 2014:
		March 31, 2015		December 31, 2014
	Purchased Parts and Components	$	923,363	$	1,251,224
	Work in Process		14,702		25,974
	Finished Goods		405,577		300,889
	Less: Reserve for Obsolescence		-330,175		-666,138
	Net	$	1,013,467	$	911,949

Notes_Payable

Notes Payable	3 Months Ended
	Mar. 31, 2015
Notes Payable [Abstract]
Notes Payable	Note 4 — Notes Payable
	Notes payable represent promissory notes payable by the Company.
		March 31,  2015		December 31, 2014
	Note payable to officers and shareholders of the Company. Principal along with accrued interest is payable on demand. The notes bear interest at 18.5% and secured by all the assets of the Company.	$	—	$	37,038
		$	—	$	37,038

Accrued_Expenses

Accrued Expenses	3 Months Ended
	Mar. 31, 2015
Payables and Accruals [Abstract]
Accrued Expenses	Note 5 — Accrued Expenses
	Accrued expenses consisted of the following:
		March 31, 2015		December 31, 2014
	Accrued Wages and Related Costs	$	91,134	$	101,445
	Accrued Compensation		417,286		428,786
	Accrued Professional Services		33,500		45,000
	Accrued Warranty Obligations		45,623		39,624
	Accrued Interest		85,191		75,471
	Other Accrued Expenses		1,003		8,741
	Total	$	673,737	$	699,067
	Included in the above accrued compensation are amounts owed to officers of the Company for services rendered that remain outstanding. These amounts are not subject to a fixed repayment schedule and they bear interest at a rate of 8% per annum, compounding monthly. The amounts were $386,036 as of March 31, 2015 and $393,526 as of December 31, 2014. The related interest amounts included in Accrued Interest were $71,076 and $62,801 respectively as of March 31, 2015 and December 31, 2014. The related interest expense amounts for the three months ended March 31, 2015 and 2014 were $8,994 and $7,338 respectively.
	The Company has warranty obligations in connection with the sale of certain of its products. The warranty period for its products is generally one year except in certain European countries where it is two years. The costs incurred to provide for these warranty obligations are estimated and recorded as an accrued liability at the time of sale. The Company estimates its future warranty costs based on product-based historical performance rates and related costs to repair. The changes in the Company’s accrued warranty obligations for the three months ended March 31, 2015 were as follows:
	Accrued Warranty Obligations at December 31, 2014	$	39,624
	Reductions for Settling Warranties		-21,948
	Warranties Issued During Period		27,947
	Accrued Warranty Obligations at March 31, 2015	$	45,623

Derivative_Liability_and_Fair_

Derivative Liability and Fair Value Measurements	3 Months Ended
	Mar. 31, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability and Fair Value Measurements	Note 6 – Derivative Liability and Fair Value Measurements
	The Company recognized a derivative liability for the warrants to purchase shares of its common stock issued in connection with the public equity offering and related debt conversions on August 5, 2013. These warrants have a cashless exercise provision and an exercise price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions) along with full-ratchet anti-dilution provisions. In accordance with ASC 815-10-25, we measured the derivative liability using a Monte Carlo Options Lattice pricing model at their issuance date and subsequently remeasured the liability on each reporting date.
	Accordingly, at the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value. As at March 31, 2015 a total of 52,600 of these warrants were outstanding and as at December 31, 2014 a total of 4,730,992 warrants were outstanding that contained a full-ratchet anti-dilution provision. In connection with the Series A Private Placement on January 2, 2015 (see Note 9), holders of approximately 86% of outstanding warrants issued by the Company in its public offering and in connection with the conversion by certain holders of the Company’s outstanding debt in connection with the Company’s public offering(collectively, the “Public Offering Warrants”) agreed to irrevocably waive their rights to anti-dilution protection under Section 2(b) of the Public Offering Warrants in the event the Company issues additional securities at a per share price lower than the exercise price of the Public Offering Warrants (the “Public Offering Warrant Waiver”). As a result the related derivative liability was reversed to Nil and reclassified into stockholders equity under Additional Paid-In Capital.
	The Company recognized a derivative liability during the year ended December 31, 2014 for the $3,000,000 of senior convertible notes with a conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). In accordance with FASB ASC 815-10-25, we measured the derivative liability of this embedded conversion option using a Monte Carlo Options Lattice pricing model at the June 3, 2014 issuance date as $1,938,988. The value of the derivative liability at issuance was recorded as a discount against the notes in the Long-Term Liabilities section of the balance sheet which is amortized into interest expense over the term of the related note. At the end of each quarterly reporting date the derivative fair market value is remeasured and adjusted to current market value through earnings.
	In connection with the Series A Private Placement on January 2, 2015, each of the holders of notes issued by the Company on June 3, 2014 (the “June 2014 Notes”) agreed to irrevocably waive their rights to anti-dilution protection under Section 5(b) of the June 2014 Notes in the event the Company issues additional securities at a per share price lower than the conversion price of the June 2014 Notes (the “June 2014 Note Waiver”). As a result this derivative liability was reversed to Nil and reclassified into stockholders equity under Additional Paid-In Capital. For period ending December 31, 2014, the Monte Carlo Options Lattice pricing model was used to estimate the fair value of the embedded conversion option on the convertible notes issued during this period.
	The Company has adopted FASB ASC Topic 820 for financial instruments measured at fair value on a recurring basis. ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements.
	Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. FASB ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include:
	-             Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
	-             Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
	-             Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	The Company’s financial instruments primarily consists of cash and cash equivalents, accounts receivable, accounts payable, lines of credit, long-term debt and capital leases, customer deposits, accrued expenses, and income taxes payable.
	As of the consolidated balance sheet dates, the estimated fair values of the financial instruments were not materially different from their carrying values as presented due to both the short maturities of these instruments and that the interest rates on borrowing approximate those that would have been available for loans for similar remaining maturity and risk profiles.
	We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at March 31, 2015:
		Total		(Level 1)		(Level 2)		Level (3)
	Assets	$	—	$	—	$	—	$	—
	Total assets measured at fair value		—		—		—		—
	Liabilities
	Note Conversion Feature Liability		—		—		—		—
	Warrant Liability		175,158		—		—		175,158
	Total liabilities measured at fair value (Long-Term)	$	175,158	$	—	$	—	$	175,158
	We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2014:
		Total		(Level 1)		(Level 2)		Level (3)
	Assets	$	—	$	—	$	—	$	—
	Total assets measured at fair value		—		—		—		—
	Liabilities
	Note Conversion Feature Liability		2,806,942		—		—		2,806,942
	Warrant Liability		10,734,196		—		—		10,734,196
	Total liabilities measured at fair value (Long-Term)	$	13,541,138	$	—	$	—	$	13,541,138
	Fair value – December 31, 2014		13,541,138
	Reclassification of warrant exercises to Additional Paid-in Capital		-2,826,053
	Change in fair value for the period of warrant derivative liability		1,003,427
	Reclassification of embedded debt conversion price adjustment provision liability to Additional Paid-in Capital upon waiver of certain anti-dilutive provisions		-2,806,942
	Reclassification of warrant exercise price adjustment provision liability to Additional Paid-in Capital upon waiver of certain anti-dilutive provisions		-8,736,412
	Fair value – March 31, 2015	$	175,158
	The Monte Carlo Options Lattice pricing model was used to estimate the fair value of the warrant liability outstanding:
		March 31, 2015		December 31, 2014
	Assumptions for Pricing Model:
	Expected term in years		3.35 to 3.59		3.59 to 3.78
	Volatility range for years		89 to 90%		81 to 89%
	Risk-free interest rate		0.89 to 1.06%		0.83 to 1.11%
	Expected annual dividends		None		None
	Value of warrants outstanding:
	Fair value of warrants	$	175,158	$	10,734,196

LongTerm_Debt

Long-Term Debt	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Long-Term Debt	Note 7 — Long-Term Debt
	Long-term debt consisted of the following:
		March 31,		December 31,
		2015		2014
	Note payable for research and development equipment. The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months. The note carries a 0% interest rate.		130,836		186,131
	The note carries a 0% interest, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal.		-40,074		-46,399
	Note payable for which the principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per annum and is secured by a subordinated position in all the assets of the Company.		42,395		50,874
	Convertible, Senior Secured Notes payable. The principal is due June 3, 2017 and no principal payments are required. The notes carry a 5% interest, payable upon the note’s maturity. Both the interest plus accrued interest is convertible into shares of the Company’s common shares at $2.25, subject to normal adjustments. The notes are secured by a first security position in all the assets of the Company.		2,037,500		2,375,000
	Unamortized debt discount related to derivative liability associated with above notes’ conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988.		-1,013,551		-1,348,185
		$	1,157,106	$	1,217,421
	Less: Amount Due Within One Year		-80,097		-128,425
	Amount Due After One Year	$	1,077,009	$	1,088,996
	The calendar year aggregate maturities for all long-term borrowings exclusive of discounts as of March 31, 2015 are as follows:
	Total Aggregate Maturity For Period	Amounts
	2015	$	114,088
	2016		59,143
	2017		2,037,500
	Total Required Principal Payments Exclusive of Debt Discounts		2,210,731
	Total Unamortized Debt Discounts		-1,053,625
	Total Net Long-Term Borrowings as of March 31, 2015	$	1,157,106

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Income Taxes	Note 8 — Income Taxes
	The Company’s effective income tax rate is a combination of federal, state and foreign tax rates and differs from the U.S. statutory rate due to taxes on foreign income, permanent differences including tax-exempt interest, and the resolution of tax uncertainties, offset by a valuation allowance against U.S. deferred income tax assets.

Preferred_Stock

Preferred Stock	3 Months Ended
	Mar. 31, 2015
Equity [Abstract]
Preferred Stock	Note 9 — Preferred Stock
	The Company may issue shares of undesignated preferred stock in one or more series. The Board of Directors is authorized to establish and designate the different series and to fix and determine the voting powers and other special rights and qualifications. A total of 5,000,000 shares of preferred stock are authorized as of March 31, 2015 and December 31, 2014.
	On January 2, 2015 (the “Series A Closing Date”), we entered into and closed a Series A Preferred Stock Purchase Agreement (the “Series A Purchase Agreement”) with Intel Corporation (the “Series A Purchaser”), pursuant to which we issued and sold to the Series A Purchaser, an aggregate of 49,626 shares of the Company’s Series A Preferred Stock, at a purchase price of $500 per share, for an aggregate purchase price of $24,813,000 (the “Series A Private Placement”). Each share of Series A Preferred Stock is convertible, at the option of the Series A Purchaser, into 100 shares of the Company’s common stock (determined by dividing the Series A Original Issue Price of $500 by the Series A Conversion Price. The Series A Conversion Price is $5.00, subject to adjustment in the event of stock splits, dividends or other combinations). Total costs incurred connection with this offering were approximately $222,000.
	Each share of Series A Preferred Stock is entitled to receive dividends at a rate of 6% per annum, compounded quarterly and payable in cash or in kind, at the Company’s sole discretion. In the event of the liquidation, dissolution or winding up of the Company, each share of Series A Preferred Stock is entitled to a liquidation preference equal to one times (1x) the Series A Purchaser’s original per share purchase price, plus a right to receive an additional liquidation distribution together with the common stock holders pro rata on an as converted basis, but not in excess of $1,000 per share in the aggregate (subject to adjustment for accrued but unpaid dividends and in the event of stock splits, dividends or other combinations). Each share of Series A Preferred Stock is entitled to vote with the holders of the Company’s common stock on matters presented to its stockholders, and is entitled to cast such number of votes equal to the whole number of shares of common stock into which such shares of Series A Preferred Stock are convertible. The holders of record of the Series A Preferred Stock will be entitled to nominate and elect 2 directors to the Company’s Board of Directors (the “Board Election Right”), at least one of whom will be required to qualify as an “independent” director, as that term is used in applicable exchange listing rules. The Board Election Right with respect to the independent director will terminate on such date as the number of shares of Series A Preferred Stock then outstanding is less than 40% of the original amount purchased by the Series A Purchaser. The Board Election Right with respect to the second director shall terminate on such date as the number of shares of Series A Preferred Stock then outstanding is less than 20% of the original amount purchased by the Series A Purchaser. The Company also granted the Series A Purchaser the right to have a board observer at meetings of the Company’s Board of Directors and committees thereof.
	For as long as at least 25% (or 12,406 shares) of the Series A Preferred Stock is outstanding, the Company may not, without the consent of holders of at least 60% of the then outstanding shares of Series A Preferred Stock, take certain actions, including but not limited to: (i) liquidate, dissolve, or wind up the business and affairs of the Company; (ii) amend, alter or repeal any provision of its charter or bylaws in a manner that adversely effects the rights of the Series A Preferred Stock; (iii) create or issue any capital stock that is equal to or senior to the Series A Preferred Stock with respect to preferences; (iv) create or issue any debt security, subject to certain exceptions; (v) pay off any debt obligation prior to its stated maturity date; or (vi) enter into any stockholders rights plan or similar arrangement or take other actions that may limit actions that holders of a majority of the Series A Preferred Stock can take under Section 203 (“Section 203”) of the Delaware General Corporation Law, as well as such other customary provisions protecting the rights of the holder of the Series A Preferred Stock, as are outlined in the Certificate of Designation.
	The Series A Purchaser has the right to participate in any proposed issuance by the Company of its securities, subject to certain exceptions (the “Participation Right”). In the event the Series A Purchaser is not afforded the opportunity to exercise its Participation Right, the Series A Purchaser will have the right, but not the obligation, up to two times per calendar year, to acquire additional securities from the Company in such amount as is sufficient to maintain the Series A Purchaser’s ownership percentage in the Company, calculated immediately prior to such applicable financing, at a purchase price equal to the per share price of the Company’s securities in such applicable financing.
	In connection with the Series A Private Placement, the Company entered into an investor’s rights agreement with the Series A Purchaser, pursuant to which the Company agreed to file a “resale” registration statement with the Securities and Exchange Commission (the “SEC”) covering all shares of common stock issuable upon conversion of the Series A Preferred Stock sold in the Series A Private Placement on or before February 14, 2015.  The Company filed the registration statement on February 12, 2015 and the registration statement was declared effective by SEC on February 17, 2015.

Stock_Warrants

Stock Warrants	3 Months Ended
	Mar. 31, 2015
Stockholders' Equity Note [Abstract]
Stock Warrants	Note 10 — Stock Warrants
	A summary of the various changes in warrants during the three-month period ended March 31, 2015 is as follows.
		Number of Shares
	Warrants Outstanding at December 31, 2014		5,236,660
	Exercised During the Period		-4,699,017
	Issued During the Period		60,000
	Expired During the Period		—
	Warrants Outstanding, March 31, 2015		597,643
	The outstanding warrants as of March 31, 2015 expire from May 21, 2015 to August 5, 2018. The weighted average remaining term of the warrants is 2.9 years. The weighted average exercise price is $2.56 per share.
	The Black-Scholes-Merton pricing model was used to estimate the fair value of share-based awards under FASB ASC Topic 718. The Black-Scholes-Merton pricing model incorporates various and highly subjective assumptions, including expected term and expected volatility.
	The following shows the assumptions used to compute the fair value of warrants granted during the three period ending March 31, 2015 for investor relations services and their estimated value:
	⋅         Expected term in years 2.8 to 3.0 years
	⋅         Volatility 122.8 to 122.9%
	⋅         Risk-free interest rate 0.90 to 0.99%
	⋅         Expected annual dividends None
	⋅         Fair value of warrants issued $260,373
	Unrecognized warrant-based compensation expense was approximately $61,082 as of March 31, 2015, relating to the unamortized period of services remaining under the arrangements for which the warrants were issued. The entire unamortized amount will be recognized in the second quarter ending June 30, 2015.

Stock_Option_Plans

Stock Option Plans	3 Months Ended
	Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Option Plans	Note 11 — Stock Option Plans
	A summary of stock option activity for the three months ended March 31, 2015 is as follows:
				Weighted
		Number of		Average		Exercise Price
		Shares		Exercise Price		Range
	Outstanding at December 31, 2014		720,551	$	4.46	$	1.71 – $ 17.50
	Granted		—	$	—	$	—
	Exercised		—	$	—	$	—
	Expired or Forfeited		—	$	—	$	—
	Outstanding at March 31, 2015		720,551	$	4.46	$	1.71 – $ 17.50
	As of March 31, 2015, there were 304,337 options that were fully vested and exercisable at a weighted average exercise price of $6.95 per share. The weighted average remaining contractual term on the vested options is 6.9 years.
	As of March 31, 2015 there were 416,214 unvested options exercisable at a weighted average exercise price of $2.63 per share. The weighted average remaining contractual term on the unvested options is 9.3 years.
	No cash was received from option exercises for the three months ended March 31, 2015 and 2014.
	The weighted average fair value of option grants was calculated using the Black-Scholes-Merton option pricing method. At March 31, 2015, the Company had approximately $957,291 of unrecognized stock compensation expense, which will be recognized over a weighted average period of approximately 2.0 years.

Litigation

Litigation	3 Months Ended
	Mar. 31, 2015
Litigation Disclosure [Abstract]
Litigation	Note 12 — Litigation
	We are not currently involved in any pending legal proceeding or litigation.

Contractual_Obligations

Contractual Obligations	3 Months Ended
	Mar. 31, 2015
Contractual Obligations [Abstract]
Contractual Obligations	Note 13 — Contractual Obligations
	The Company leases office and manufacturing space under operating leases that expire on September 30, 2015 through to March 1, 2016. The Company’s total contractual payment obligations for operating leases as of March 31, 2015 total $66,800.

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements	3 Months Ended
	Mar. 31, 2015
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	Note 14 — Recent Accounting Pronouncements
	FASB ASU 2015-1, Income Statement—Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items This ASU eliminates from GAAP the concept of extraordinary items. ASU 2015-1 is effective for the annual period ending after December 15, 2015. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption.
	FASB ASU 2015-03—Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs. This ASU requires that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability (same treatment as debt discounts). ASU 2015-3 is effective for the annual periods beginning after December 15, 2015. Early adoption is permitted for financial statements that not have been previously issued.
	There are no other recent accounting pronouncements that are expected to have a material impact on the condensed consolidated financial statements.

Inventories_Net_Tables

Inventories, Net (Tables)	3 Months Ended
	Mar. 31, 2015
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories are stated at the lower of cost (determined on the first-in, first-out or specific identification method) or market and consisted of the following as at March 31, 2015 and December 31, 2014:
		March 31, 2015		December 31, 2014
	Purchased Parts and Components	$	923,363	$	1,251,224
	Work in Process		14,702		25,974
	Finished Goods		405,577		300,889
	Less: Reserve for Obsolescence		-330,175		-666,138
	Net	$	1,013,467	$	911,949

Notes_Payable_Tables

Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2015
Notes Payable [Abstract]
Notes payable represent promissory notes payable	Notes payable represent promissory notes payable by the Company.
		March 31,  2015		December 31, 2014
	Note payable to officers and shareholders of the Company. Principal along with accrued interest is payable on demand. The notes bear interest at 18.5% and secured by all the assets of the Company.	$	—	$	37,038
		$	—	$	37,038

Accrued_Expenses_Tables

Accrued Expenses (Tables)	3 Months Ended
	Mar. 31, 2015
Payables and Accruals [Abstract]
Components of Accrued Expenses	Accrued expenses consisted of the following:
		March 31, 2015		December 31, 2014
	Accrued Wages and Related Costs	$	91,134	$	101,445
	Accrued Compensation		417,286		428,786
	Accrued Professional Services		33,500		45,000
	Accrued Warranty Obligations		45,623		39,624
	Accrued Interest		85,191		75,471
	Other Accrued Expenses		1,003		8,741
	Total	$	673,737	$	699,067
Changes in Accrued Warranty Obligations	The changes in the Company’s accrued warranty obligations for the three months ended March 31, 2015 were as follows:
	Accrued Warranty Obligations at December 31, 2014	$	39,624
	Reductions for Settling Warranties		-21,948
	Warranties Issued During Period		27,947
	Accrued Warranty Obligations at March 31, 2015	$	45,623

Derivative_Liability_and_Fair_1

Derivative Liability and Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule Of Assets And Liabilities Measured At Fair Value On A Recurring Basis	We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at March 31, 2015:
		Total		(Level 1)		(Level 2)		Level (3)
	Assets	$	—	$	—	$	—	$	—
	Total assets measured at fair value		—		—		—		—
	Liabilities
	Note Conversion Feature Liability		—		—		—		—
	Warrant Liability		175,158		—		—		175,158
	Total liabilities measured at fair value (Long-Term)	$	175,158	$	—	$	—	$	175,158
	We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2014:
		Total		(Level 1)		(Level 2)		Level (3)
	Assets	$	—	$	—	$	—	$	—
	Total assets measured at fair value		—		—		—		—
	Liabilities
	Note Conversion Feature Liability		2,806,942		—		—		2,806,942
	Warrant Liability		10,734,196		—		—		10,734,196
	Total liabilities measured at fair value (Long-Term)	$	13,541,138	$	—	$	—	$	13,541,138
Schedule of Fair Value Level 3 warrant liabilities	Fair value – December 31, 2014		13,541,138
	Reclassification of warrant exercises to Additional Paid-in Capital		-2,826,053
	Change in fair value for the period of warrant derivative liability		1,003,427
	Reclassification of embedded debt conversion price adjustment provision liability to Additional Paid-in Capital upon waiver of certain anti-dilutive provisions		-2,806,942
	Reclassification of warrant exercise price adjustment provision liability to Additional Paid-in Capital upon waiver of certain anti-dilutive provisions		-8,736,412
	Fair value – March 31, 2015	$	175,158
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques	The Monte Carlo Options Lattice pricing model was used to estimate the fair value of the warrant liability outstanding:
		March 31, 2015		December 31, 2014
	Assumptions for Pricing Model:
	Expected term in years		3.35 to 3.59		3.59 to 3.78
	Volatility range for years		89 to 90%		81 to 89%
	Risk-free interest rate		0.89 to 1.06%		0.83 to 1.11%
	Expected annual dividends		None		None
	Value of warrants outstanding:
	Fair value of warrants	$	175,158	$	10,734,196

LongTerm_Debt_Tables

Long-Term Debt (Tables)	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Components of Long-Term Debt	Long-term debt consisted of the following:
		March 31,		December 31,
		2015		2014
	Note payable for research and development equipment. The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months. The note carries a 0% interest rate.		130,836		186,131
	The note carries a 0% interest, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal.		-40,074		-46,399
	Note payable for which the principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013. The loan bears interest at 12% per annum and is secured by a subordinated position in all the assets of the Company.		42,395		50,874
	Convertible, Senior Secured Notes payable. The principal is due June 3, 2017 and no principal payments are required. The notes carry a 5% interest, payable upon the note’s maturity. Both the interest plus accrued interest is convertible into shares of the Company’s common shares at $2.25, subject to normal adjustments. The notes are secured by a first security position in all the assets of the Company.		2,037,500		2,375,000
	Unamortized debt discount related to derivative liability associated with above notes’ conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988.		-1,013,551		-1,348,185
		$	1,157,106	$	1,217,421
	Less: Amount Due Within One Year		-80,097		-128,425
	Amount Due After One Year	$	1,077,009	$	1,088,996
Aggregate maturities for all long-term borrowings	The calendar year aggregate maturities for all long-term borrowings exclusive of discounts as of March 31, 2015 are as follows:
	Total Aggregate Maturity For Period	Amounts
	2015	$	114,088
	2016		59,143
	2017		2,037,500
	Total Required Principal Payments Exclusive of Debt Discounts		2,210,731
	Total Unamortized Debt Discounts		-1,053,625
	Total Net Long-Term Borrowings as of March 31, 2015	$	1,157,106

Stock_Warrants_Tables

Stock Warrants (Tables)	3 Months Ended
	Mar. 31, 2015
Stockholders' Equity Note [Abstract]
Changes in Warrants	A summary of the various changes in warrants during the three-month period ended March 31, 2015 is as follows.
		Number of Shares
	Warrants Outstanding at December 31, 2014		5,236,660
	Exercised During the Period		-4,699,017
	Issued During the Period		60,000
	Expired During the Period		—
	Warrants Outstanding, March 31, 2015		597,643

Stock_Option_Plans_Tables

Stock Option Plans (Tables)	3 Months Ended
	Mar. 31, 2015
Stock Option Plans [Abstract]
Stock option plans	A summary of stock option activity for the three months ended March 31, 2015 is as follows:
				Weighted
		Number of		Average		Exercise Price
		Shares		Exercise Price		Range
	Outstanding at December 31, 2014		720,551	$	4.46	$	1.71 – $ 17.50
	Granted		—	$	—	$	—
	Exercised		—	$	—	$	—
	Expired or Forfeited		—	$	—	$	—
	Outstanding at March 31, 2015		720,551	$	4.46	$	1.71 – $ 17.50

Earnings_Loss_Per_Share_Additi

Earnings (Loss) Per Share (Additional Information) (Detail)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		1,544,999
Earnings Per Share, Potentially Dilutive Securities	7,186,350		7,012,767

Inventories_Net_Components_of_

Inventories, Net (Components of Inventories) (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Inventory Disclosure [Line Items]
Purchased Parts and Components	$923,363	$1,251,224
Work in Process	14,702	25,974
Finished Goods	405,577	300,889
Less: Reserve for Obsolescence	-330,175	-666,138
Net	$1,013,467	$911,949

Notes_Payable_Notes_Payable_Re

Notes Payable (Notes Payable Represent Promissory Notes) (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Notes and Promissory Notes [Line Items]
Notes Payable	$0	$37,038
Officer and Shareholders [Member]
Notes and Promissory Notes [Line Items]
Notes Payable	$0	$37,038

Notes_Payable_Notes_Payable_Re1

Notes Payable (Notes Payable Represent Promissory Notes) (Parenthetical) (Detail) (Officer and Shareholders [Member])	Mar. 31, 2015
Officer and Shareholders [Member]
Notes and Promissory Notes [Line Items]
Interest percentage	18.50%

Accrued_Expenses_Components_of

Accrued Expenses (Components of Accrued Expenses) (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Accrued Liabilities [Line Items]
Accrued Wages and Related Costs	$91,134	$101,445
Accrued Compensation	417,286	428,786
Accrued Professional Services	33,500	45,000
Accrued Warranty Obligations	45,623	39,624
Accrued Interest	85,191	75,471
Other Accrued Expenses	1,003	8,741
Total	$673,737	$699,067

Accrued_Expenses_Changes_in_Ac

Accrued Expenses (Changes in Accrued Warranty Obligations) (Detail) (USD $)	3 Months Ended
	Mar. 31, 2015
Class Of Warrant Or Right [Line Items]
Accrued Warranty Obligations , begining balance	$39,624
Reductions for Settling Warranties	-21,948
Warranties Issued During Period	27,947
Accrued Warranty Obligations , Ending balance	$45,623

Accrued_Expenses_Additional_In

Accrued Expenses - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Officers Compensation Payable Compounding Monthly Interest Rate	8.00%
Employee-related Liabilities, Current	$386,036	$393,526
Interest Payable	71,076	62,801
Interest Payable, Current	$8,994	$7,338

Derivative_Liability_and_Fair_2

Derivative Liability and Fair Value Measurements (Schedule of Assets And Liabilities Measured At Fair Value On A Recurring Basis) (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	$0	$0
Total assets measured at fair value	0	0
Note Conversion Feature Liability	0	2,806,942
Warrant Liability	175,158	10,734,196
Total liabilities measured at fair value (Long-Term)	175,158	13,541,138
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	0	0
Total assets measured at fair value	0	0
Note Conversion Feature Liability	0	0
Warrant Liability	0	0
Total liabilities measured at fair value (Long-Term)	0	0
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	0	0
Total assets measured at fair value	0	0
Note Conversion Feature Liability	0	0
Warrant Liability	0	0
Total liabilities measured at fair value (Long-Term)	0	0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets	0	0
Total assets measured at fair value	0	0
Note Conversion Feature Liability	0	2,806,942
Warrant Liability	175,158	10,734,196
Total liabilities measured at fair value (Long-Term)	$175,158	$13,541,138

Derivative_Liability_and_Fair_3

Derivative Liability and Fair Value Measurements (Schedule of Fair Value Level 3 Warrant Liabilities) (Detail) (Warrant Liabilities [Member], USD $)	3 Months Ended
	Mar. 31, 2015
Warrant Liabilities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value -beginning of period	$13,541,138
Reclassification of warrant exercises to Additional Paid-in Capital	-2,826,053
Change in fair value for the period of warrant derivative liability	1,003,427
Reclassification of embedded debt conversion price adjustment provision liability to Additional Paid-in Capital upon waiver of certain anti-dilutive provisions	-2,806,942
Reclassification of warrant exercise price adjustment provision liability to Additional Paid-in Capital upon waiver of certain anti-dilutive provisions	-8,736,412
Fair value - end of period	$175,158

Derivative_Liability_and_Fair_4

Derivative Liability and Fair Value Measurements (Estimate the fair value of warrants outstanding) (Detail) (Monte Carlo Options Lattice Pricing Model Warrants Outstanding [Member], USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Value of warrants outstanding:
Fair value of warrants	175,158	10,734,196
Minimum [Member]
Assumptions for Pricing Model:
Expected term in years	3 years 4 months 6 days	3 years 7 months 2 days
Volatility range for years	89.00%	81.00%
Risk-free interest rate	0.89%	0.83%
Maximum [Member]
Assumptions for Pricing Model:
Expected term in years	3 years 7 months 2 days	3 years 9 months 11 days
Volatility range for years	90.00%	89.00%
Risk-free interest rate	1.06%	1.11%

Derivative_Liability_and_Fair_5

Derivative Liability and Fair Value Measurements (Additional Information) (Detail) (USD $)	0 Months Ended	3 Months Ended
	Jun. 03, 2014	Mar. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right		52,600	4,730,992
Convertible Debt			$3,000,000
Fair Value Of Debt Embedded Conversion Price Adjustment Option	$1,938,988
Series A Private Placement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Class of Warrant or Right Outstanding Percentage		86.00%

LongTerm_Debt_Components_of_Lo

Long-Term Debt (Components of Long-Term Debt) (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Long term debt	$1,157,106	$1,217,421
Less: Amount Due Within One Year	-80,097	-128,425
Amount Due After One Year	1,077,009	1,088,996
The note carries a 0% interest, but imputed interest has been accrued based on a 12% discount rate and is reflected as a reduction in the principal [Member]
Debt Instrument [Line Items]
Long term debt	-40,074	-46,399
Convertible to shares of the Company's common shares at 2.25, subject to adjustment [Member]
Debt Instrument [Line Items]
Long term debt	2,037,500	2,375,000
Unamortized debt discount related to derivative liability associated with above notesb conversion price that is subject to adjustment in the event of subsequent equity sales at a lower purchase price (subject to certain exceptions). Upon issuance on June 3, 2014 the discount was $1,938,988 [Member]
Debt Instrument [Line Items]
Unamortized Debt Discount Related To Derivative Liability	-1,013,551	-1,348,185
Notes Payable [Member] | The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months [Member]
Debt Instrument [Line Items]
Long term debt	130,836	186,131
Notes Payable [Member] | The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013 [Member]
Debt Instrument [Line Items]
Long term debt	$42,395	$50,874

LongTerm_Debt_Components_of_Lo1

Long-Term Debt (Components of Long-Term Debt) (Parenthetical) (Detail) (USD $)	0 Months Ended	3 Months Ended	12 Months Ended
	Jun. 03, 2014	Mar. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Fair Value Of Debt Embedded Conversion Price Adjustment Option	$1,938,988
Notes Payable [Member] | The principal is subject to a fixed semi-annual repayment schedule commencing October 31, 2013 over 48 months [Member]
Debt Instrument [Line Items]
Long term debt, fixed interest repayment term		48 months	48 months
Long term debt repayment starting date		31-Oct-13	31-Oct-13
Long term debt, fixed interest rate		0.00%	12.00%
Notes Payable [Member] | The principal and interest is subject to a fixed blended repayment schedule of 36 months, commencing July 15, 2013 [Member]
Debt Instrument [Line Items]
Long term debt, fixed interest repayment term		36 months
Long term debt repayment starting date		15-Jul-13	15-Jul-13
Long term debt, fixed interest rate		12.00%	12.00%
Convertible Senior Secured Notes payable [Member]
Debt Instrument [Line Items]
Long term debt repayment starting date		3-Jun-17	3-Jun-17
Long term debt, fixed interest rate		5.00%	5.00%
Debt Instrument, Convertible, Conversion Price		2.25	2.25

LongTerm_Debt_Aggregate_Maturi

Long-Term Debt (Aggregate Maturities For All Long Term Borrowings) (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
2015	$114,088
2016	59,143
2017	2,037,500
Total Required Principal Payments Exclusive of Debt Discounts	2,210,731
Total Unamortized Debt Discounts	-1,053,625
Total Net Long-Term Borrowings as of March 31, 2015	$1,157,106	$1,217,421

Preferred_Stock_Additional_Inf

Preferred Stock (Additional Information) (Detail) (USD $)	3 Months Ended	0 Months Ended
	Mar. 31, 2015	Jan. 02, 2015	Dec. 31, 2014
Preferred Stock Shares Authorized	5,000,000		5,000,000
Stock Issued During Period, Value, New Issues	$1,475,000
Preferred Stock, Liquidation Preference Per Share	$1,000
Preferred Stock Shares Outstanding	49,626		0
Preferred Stock Shares Outstanding In Percent liquidation or amendment actions	60.00%
Director Two [Member]
Preferred Stock Shares Outstanding In Percent	25.00%
Director One [Member]
Preferred Stock Shares Outstanding In Percent	20.00%
Series A Preferred Stock [Member]
Preferred Stock, Dividend Rate, Percentage	6.00%
Preferred Stock Shares Outstanding	12,406
Series A Preferred Stock [Member] | Director [Member]
Preferred Stock Shares Outstanding In Percent	40.00%
Series A Preferred Stock [Member] | Corporation [Member]
Stock Issued During Period, Shares, New Issues		49,626
Shares Issued, Price Per Share		$500
Conversion of Stock, Description		Each share of Series A Preferred Stock is convertible, at the option of the Series A Purchaser, into 100 shares of the Companys common stock (determined by dividing the Series A Original Issue Price of $500 by the Series A Conversion Price. The Series A Conversion Price is $5.00, subject to adjustment in the event of stock splits, dividends or other combinations).
Stock Issued During Period, Value, New Issues		24,813,000
Payments of Stock Issuance Costs		$222,000

Stock_Warrants_Changes_in_Warr

Stock Warrants (Changes in Warrants) (Detail)	3 Months Ended
	Mar. 31, 2015
Class Of Warrant Or Right [Line Items]
Warrants Outstanding, Beginning of Period	5,236,660
Exercised During the Period	-4,699,017
Issued During the Period	60,000
Expired During the Period	0
Warrants Outstanding, End of Period	597,643

Stock_Warrants_Additional_Info

Stock Warrants (Additional Information) (Detail) (USD $)	3 Months Ended
	Mar. 31, 2015
Class of Warrant or Right [Line Items]
Weighted average term of warrants	2 years 10 months 24 days
Weighted average exercise price of warrants per share	$2.56
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	$957,291
Warrant [Member]
Class of Warrant or Right [Line Items]
Fair Value Assumptions, Expected Dividend Rate	0.00%
Warrants Issued Aggregate Fair Value	260,373
Employee Service Share-Based Compensation, Nonvested Awards, Total Compensation Cost Not Yet Recognized	$61,082
Minimum | Warrant [Member]
Class of Warrant or Right [Line Items]
Fair Value Assumptions, Expected Term	2 years 9 months 18 days
Fair Value Assumptions, Expected Volatility Rate	122.80%
Fair Value Assumptions, Risk Free Interest Rate	0.90%
Maximum | Warrant [Member]
Class of Warrant or Right [Line Items]
Fair Value Assumptions, Expected Term	3 years
Fair Value Assumptions, Expected Volatility Rate	122.90%
Fair Value Assumptions, Risk Free Interest Rate	0.99%

Stock_Option_Plans_Summary_of_

Stock Option Plans (Summary of Stock Option Activity) (Detail) (USD $)	3 Months Ended
	Mar. 31, 2015
Number of shares outstanding
Outstanding, Beginning Balance	720,551
Granted	0
Exercised	0
Expired or Forfeited	0
Outstanding, Ending Balance	720,551
Weighted Average Exercise Price
Outstanding, Beginning Balance	$4.46
Granted	$0
Exercised	$0
Expired or Forfeited	$0
Outstanding, Ending Balance	$4.46
Exercised Price Range
Outstanding, Beginning Balance, lower limit	$1.71
Outstanding, Beginning Balance, upper limit	$17.50
Granted	$0
Exercised	$0
Expired or Forfeited	$0
Outstanding, Ending Balance, lower limit	$1.71
Outstanding, Ending Balance, upper limit	$17.50

Stock_Option_Plans_Additional_

Stock Option Plans (Additional Information) (Detail) (USD $)	3 Months Ended
	Mar. 31, 2015
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Weighted average remaining contractual term on unvested options	6 years 10 months 24 days
Exercisable Options Outstanding Shares	304,337
Weighted average exercise price per share	$6.95
Unvested Options Outstanding, Shares	416,214
Unvested Options Outstanding, Weighted average exercise price	$2.63
Unvested Options Outstanding Weighted average remaining life (yrs)	9 years 3 months 18 days
Unrecognized stock compensation expense	$957,291
Weighted average recognition period	2 years

Contractual_Obligations_Additi

Contractual Obligations (Additional Information) (Detail) (USD $)	3 Months Ended
	Mar. 31, 2015
Contractual Obligation	$66,800
Description of Lessor Leasing Arrangements, Operating Leases	The Company leases office and manufacturing space under operating leases that expire on September 30, 2015 through to March 1, 2016.